Douglas Beernink, MD in Cameron Park, CA - Ophthalmology

Douglas Beernink, MD is a Ophthalmology physician based in Cameron Park, California. Douglas Beernink is licensed to practice in California (license number A23433) and his current practice location is 440 Cragmont Ct, Cameron Park, California. He can be reached at his office (for appointments etc.) via phone at (530) 672-8780.

NPI number for Douglas Beernink is 1992883656 and his current mailing address is Po Box 2030, Folsom, California. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1992883656.

Contact Information

	Douglas Beernink, MD
	440 Cragmont Ct, Cameron Park, CA 95682-8162
	(530) 672-8780
	Not Available

Physician's Profile

Full Name	Douglas Beernink
Gender	Male
Speciality	Ophthalmology
Location	440 Cragmont Ct, Cameron Park, California
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1992883656
Provider Enumeration Date: 11/01/2006
Last Update Date: 10/29/2008

Medical Identifiers

Medical identifiers for Douglas Beernink such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1992883656	NPI	-	NPPES
00A234330	Medicaid	CA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207W00000X	Ophthalmology	A23433 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Douglas Beernink is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Douglas Beernink, MD Po Box 2030, Folsom, CA 95763-2030 Ph: (530) 672-8780	Douglas Beernink, MD 440 Cragmont Ct, Cameron Park, CA 95682-8162 Ph: (530) 672-8780

News Archive

Reflecting on global health challenges, opportunities

Writing in the BMJ Blog, George Alleyne, director emeritus of the Pan American Health Organization (PAHO), reflects on global health challenges and opportunities, writing, "There have been massive changes not only in the basic health problems, but also in how we have addressed them."

New vaccine with the potential to protect against fungal pathogens

A group of scientists in Italy have developed a vaccine with the potential to protect against fungal pathogens that commonly infect humans, according to a study by Torosantucci and colleagues in the September 5 issue of The Journal of Experimental Medicine.

Generating an alternative to IVIG therapy: an interview with Professor Richard Pleass, LSTM

IVIG is a hugely successful biological with FDA approval for treating idiopathic thrombocytopenic purpura (ITP), Kawasaki disease, Guillain-Barré syndrome, Graves ophthalmopathy and numerous polyneuropathies.

Combination Lyme disease vaccine proteins patented

Scientists at the U.S. Department of Energy's Brookhaven National Laboratory and collaborators at Stony Brook University have received U.S. Patent Number 7,179,448 for developing chimeric, or "combination," proteins that may advance the development of vaccines and diagnostic tests for Lyme disease.

Douglas Beernink, MD - Ophthalmology in Cameron Park, CA